Whole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma
Multi-omics Pathways Workflow (MOPAW): An Automated Multi-omics Workflow on the Cancer Genomics Cloud.
Building a collaborative cloud platform to accelerate heart, lung, blood, and sleep research.
Addressing barriers in FAIR data practices for biomedical data.
Where science meets innovation.
Elevate Your LDTs
Inherited Cancer Testing
Perspectives on FDA’s Final Rule on Laboratory Developed Tests:
Understanding the Impacts of IVD Requirements on Test Manufacturers who are Laboratories
Consistency of Analytical Performance Characteristics and Other Observed Trends from the Validation of comprehensive Genomic Profiling LDTs by Diverse Laboratories
Velsera Clinical Genomics Knowledgebase:
Rapidly, accurately identify clinically significant variants and produce an actionable report
Orthogonal Approaches to Validate the Velsera Knowledgebase, a Precision Oncology Knowledgebase that Supports Automated Reporting of Clinically Relevant Somatic Cancer Variants.
CGW Plus: A New Standard In Clinical Genomics Reporting
A Winning Methodology: Key Criteria for Success in Launching an NGS assay
A Story of Support: Our Innovation Improves Your Results
Document library.
The Seven Bridges Platform
Accelerating your drug discovery process with Velsera's enterprise-grade bioinformatics ecosystem.
GRAF
A better approach to NGS data analysis: building a pan-genome graph containing population genetics.
Clinical Genomics Workspace
All-in-one analysis and reporting tool for clinical NGS data, enhancing the quality and efficiency of patient care delivery.
Video library.
Tackling Complexity in Oncology Biomarker Interpretation with CGW Plus.
A discussion of challenges and innovative solutions in clinical genomics workflows. Discover how laboratories leverage variant databases and medical genomics knowledge to automate and accelerate the analysis and reporting of genomic alterations in oncology. We also introduce Velsera's completely reimagined solution to these challenges, CGW Plus, showcasing its variant quality assessment, clinical evidence review, and adaptive learning and memory capabilities.
RHEO In Action: A Snapshot of Innovation
Discover how users can effortlessly automate complex bioinformatics analyses with RHEO's push-button solution, designed to handle any use case or data modality. With seamless integration into existing external systems like cloud storage buckets, local databases, and LIMS systems, RHEO accelerates the pace of discovery, leading to faster, more profound insights into your data.
Expanding Your Research Horizons: Single Cell and Spatial Transcriptomics Capabilities in Biomedical Research
Discover how single-cell RNA sequencing and spatial transcriptomics are transforming our understanding of tissue cell diversity, developmental processes, and tumor heterogeneity.
Tackling Complexity in Oncology Biomarker Interpretation with CGW Plus.
A discussion of challenges and innovative solutions in clinical genomics workflows. Discover how laboratories leverage variant databases and medical genomics knowledge to automate and accelerate the analysis and reporting of genomic alterations in oncology. We also introduce Velsera's completely reimagined solution to these challenges, CGW Plus, showcasing its variant quality assessment, clinical evidence review, and adaptive learning and memory capabilities.
RHEO In Action: A Snapshot of Innovation
Discover how users can effortlessly automate complex bioinformatics analyses with RHEO's push-button solution, designed to handle any use case or data modality. With seamless integration into existing external systems like cloud storage buckets, local databases, and LIMS systems, RHEO accelerates the pace of discovery, leading to faster, more profound insights into your data.
Expanding Your Research Horizons: Single Cell and Spatial Transcriptomics Capabilities in Biomedical Research
Discover how single-cell RNA sequencing and spatial transcriptomics are transforming our understanding of tissue cell diversity, developmental processes, and tumor heterogeneity.